肥厚型心肌病的诊断与治疗进展
Progress in Diagnosis and Treatment of Hypertrophic Cardiomyopathy
摘要: 肥厚型心肌病(Hypertrophic cardiomyopathy, HCM)是一种遗传性心肌病,以心室非对称性肥厚为解剖特点,是青少年运动猝死的最主要原因之一。近年来关于肥厚型心肌病的诊断逐渐增多,心导管检查和冠状动脉造影,心肌内膜活检,基因检测等都能对肥厚型心肌病的诊断提供帮助。其中临床最主要的诊断手段是超声心动图,心室不对称肥厚而无心室腔增大为其特征。近年来,基因检测也逐渐应用于该病的早期诊断。治疗以缓解症状和防治并发症为主,包括药物治疗和非药物治疗。
Abstract: Hypertrophic cardiomyopathy (HCM) is a hereditary cardiomyopathy characterized by asymmetric ventricular hypertrophy. It is one of the major causes of sudden death in adolescents. In recent years, the diagnosis of hypertrophic cardiomyopathy has gradually increased. Cardiac catheterization, coronary arteriography, endocardial biopsy, and genetic testing can all provide help for the diagnosis of hypertrophic cardiomyopathy. The most important clinical diagnostic means is echocardiography, which is characterized by asymmetric ventricular hypertrophy without ventricular enlargement. In recent years, genetic testing has also been gradually applied to the early diagnosis of the disease. Treatment is mainly to relieve symptoms and prevent complications, including drug therapy and non-drug therapy.
文章引用:刘洋. 肥厚型心肌病的诊断与治疗进展[J]. 临床医学进展, 2025, 15(4): 1668-1671. https://doi.org/10.12677/acm.2025.1541106

参考文献

[1] 国家心血管病中心心肌病专科联盟, 中国医疗保健国际交流促进会心血管病精准医学分会“中国成人肥厚型心肌病诊断与治疗指南2023”专家组. 中国成人肥厚型心肌病诊断与治疗指南2023 [J]. 中国循环杂志, 2023, 38(1): 1-33.
[2] 李晨赫, 李睿. 2020美国心脏学会/美国心脏病学会肥厚型心肌病诊疗指南解读[J]. 临床外科杂志, 2024, 32(1): 22-27.
[3] 姚佳音. 心脏磁共振多参数成像影像学特征与肥厚型心肌病高危室性心律失常相关性的初步研究[D]: [硕士学位论文]. 大连: 大连医科大学, 2024.
[4] 陈君美. 超声心动图联合激发试验在肥厚型心肌病运动管理中的临床应用价值[D]: [硕士学位论文]. 杭州: 浙江中医药大学, 2024.
[5] 肖丞炜. 左室压力-应变环在评估肥厚型心肌病整体及局部心肌做功中的研究[D]: [硕士学位论文]. 石家庄: 河北医科大学, 2024.
[6] Le, T., Huang, B., Pua, C.J., Tornekar, V., Schumacher-Maurer, A., Toh, D., et al. (2021) Lowering the Recommended Maximal Wall Thickness Threshold Improves Diagnostic Sensitivity in Asians with Hypertrophic Cardiomyopathy. JACC: Asia, 1, 218-226. [Google Scholar] [CrossRef] [PubMed]